Clinical trial
The Exploratory Study on Clinical Rational Use of Rivaroxaban Dosing in Elderly Chinese Population
NCT06194617 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Exploratory Study on Clinical Rational Use of Rivaroxaban Dosing in Elderly Chinese Population
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 1, 2021
- Completion date
- September 30, 2026
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulant-induced bleeding, pulmonary embolism, venous thromboembolism